PBBIF Stock: Probi AB (publ) Stock Price, Analysis & Insights
Get live PBBIF stock price $24.00, comprehensive Probi AB (publ) stock analysis, charts, news, and expert forecast. Real-time PBBIF stock data and investment insights.
Loading chart data...
Probi AB (publ) (PBBIF) Overview
Probi AB (publ) (PBBIF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, PBBIF trades at $24.00 with a market capitalization of 286.93M . Over the past 52 weeks, PBBIF has traded between $19.20 and $24.00 , with the current price positioned at approximately 100% of this range . The stock currently trades a...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 286.93M
- Current price: $24.00
- 52-week range: $19.20 - $24.00
- P/E ratio: 266.67
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Probi AB (publ) is a Swedish entity specializing in the discovery, development, production, marketing, and distribution of probiotic solutions, which it supplies to clients across the health, pharmaceutical, and food sectors. The company conducts ext...
Company Information
- CEO
- Anita Johansen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 157
Contact Information
- Website
- https://www.probi.com
- Address
- Ideongatan 1A
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 266.7)
✓ Lower volatility stock (Beta: 0.44) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Probi AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Probi AB (publ)
- ⚠Investors should consider how Probi AB (publ) fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 266.7) requires strong growth to justify
Market Cap
286.93M
P/E Ratio (TTM)
266.67
Beta
0.44
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PBBIF with peer companies:
- Price
- $6.10
- Market cap
- 307.51M
- Price
- $3.47
- Market cap
- 251.93M
- Price
- $0.29
- Market cap
- 397.22M
- Price
- $0.11
- Market cap
- 223.05M
- Price
- $2.90
- Market cap
- 245.80M
- Price
- $0.09
- Market cap
- 59.27M
- Price
- $3.65
- Market cap
- 282.54M
- Price
- $0.05
- Market cap
- 73.69M
- Price
- $1.06
- Market cap
- 150.21M
- Price
- $0.85
- Market cap
- 122.57M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.